Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5001
CALL
Oxford Industries
OXM
$535M
| $180K | ﹤0.01% |
2,000
+1,800
| +900% | +$164K |
|
5002
CALL
Unum
UNM
$14.5B
| $180K | ﹤0.01% |
4,600
-18,300
| -80% | -$683K |
|
5003
Bar Harbor Bankshares
BHB
$676M
| $179K | ﹤0.01% |
6,244
+5,130
| +461% | +$151K |
|
5004
DHT Holdings
DHT
$3.01B
| $179K | ﹤0.01% |
37,996
+31,262
| +464% | +$141K |
|
5005
CALL
Factset
FDS
$9.94B
| $179K | ﹤0.01% |
800
-900
| -53% | -$195K |
|
|
KREF
5006
KKR Real Estate Finance Trust
KREF
$489M
| $179K | ﹤0.01% |
8,865
+7,179
| +426% | +$147K |
|
5007
CALL
Reliance Steel & Aluminium
RS
$21.7B
| $179K | ﹤0.01% |
2,100
-17,000
| -89% | -$1.5M |
|
5008
PUT
Universal Health Services
UHS
$9.93B
| $179K | ﹤0.01% |
1,400
-500
| -26% | -$61.4K |
|
5009
Aclaris Therapeutics
ACRS
$868M
| $178K | ﹤0.01% |
12,243
+10,279
| +523% | +$176K |
|
5010
PUT
Brighthouse Financial
BHF
$3.42B
| $178K | ﹤0.01% |
4,014
| – | – |
|
5011
FRP Holdings
FRPH
$425M
| $178K | ﹤0.01% |
5,746
+4,710
| +455% | +$151K |
|
5012
PUT
MarketAxess Holdings
MKTX
$5.72B
| $178K | ﹤0.01% |
+1,000
| New | +$192K |
|
5013
Limoneira
LMNR
$253M
| $177K | ﹤0.01% |
6,781
+5,886
| +658% | +$164K |
|
5014
CALL
O-I Glass
OI
$1.06B
| $177K | ﹤0.01% |
9,400
-200
| -2% | -$3.6K |
|
5015
PUT
Teekay
TK
$1.02B
| $177K | ﹤0.01% |
26,200
-22,300
| -46% | -$154K |
|
|
CA
5016
PUT
DELISTED
CA, Inc.
CA
| $177K | ﹤0.01% |
4,000
-1,600
| -29% | -$69K |
|
|
SPN
5017
CALL
DELISTED
Superior Energy Services, Inc.
SPN
| $177K | ﹤0.01% |
1,820
+1,670
| +1,113% | +$157K |
|
5018
Blue Bird Corp
BLBD
$2.04B
| $176K | ﹤0.01% |
7,164
-4,203
| -37% | -$96.6K |
|
5019
FreightCar America
RAIL
$249M
| $176K | ﹤0.01% |
10,986
+9,042
| +465% | +$156K |
|
5020
iShares MSCI Switzerland ETF
EWL
$2.22B
| $175K | ﹤0.01% |
5,058
-1,486
| -23% | -$50.9K |
|
5021
CALL
Hartford Financial Services
HIG
$38.1B
| $175K | ﹤0.01% |
3,500
-8,900
| -72% | -$457K |
|
|
OXFD
5022
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $175K | ﹤0.01% |
10,829
+7,651
| +241% | +$109K |
|
|
EIDX
5023
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $175K | ﹤0.01% |
+17,516
| New | +$288K |
|
|
AKAO
5024
DELISTED
Achaogen Inc
AKAO
| $175K | ﹤0.01% |
43,963
+36,592
| +496% | +$221K |
|
|
HES.PRA
5025
DELISTED
Hess Corporation
HES.PRA
| $175K | ﹤0.01% |
2,200
| – | – |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.